Trial Profile
A study to evaluate micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 18 Nov 2015 New trial record